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Background: In this study, we searched for proteins that change their expression in the olfactory bulb (oB) of rats
during ontogenesis. Up to now, protein expression differences in the developing animal are not fully understood.
Our investigation focused on the question whether specific proteins exist which are only expressed during different
development stages. This might lead to a better characterization of the microenvironment and to a better
determination of factors and candidates that influence the differentiation of neuronal progenitor cells.
Results: After analyzing the samples by two-dimensional polyacrylamide gel electrophoresis (2DE) and matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS), it could be shown that the number of
expressed proteins differs depending on the developmental stages. Especially members of the functional classes, like
proteins of biosynthesis, regulatory proteins and structural proteins, show the highest differential expression in the
stages of development analyzed.
Conclusion: In this study, quantitative changes in the expression of proteins in the oB at different developmental
stages (postnatal days (P) 7, 90 and 637) could be observed. Furthermore, the expression of many proteins was found
at specific developmental stages. It was possible to identify these proteins which are involved in processes like support
of cell migration and differentiation.
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The aim of this study was to analyze the differential prote-
ome of the rat olfactory bulb (oB) within different devel-
opmental stages (7-day-old juvenile rats (P7), 90-day-old
adult rats (P90) and 637-day-old aged rats (P637)).
The postnatal development of the oB corresponds to a
bulging of the cerebral hemispheres. It develops from
the cerebral vesicle near the placode. At the time of
birth, the oB is one of the most rostral regions of the
rat brain [1].
In addition, the oB integrates different neuronal mi-
crocircuits which are of fundamental physiological im-
portance for olfaction. It has a particular source of
sensory input (axons from olfactory receptor neurons of* Correspondence: schmitt@med.uni-rostock.de
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unless otherwise stated.the olfactory epithelium) and one output source (mitral
cell axons) which work as a filter to enhance the sensi-
tivity of odor detection and its information processing
[2]. The sensory input is created by axons from olfactory
receptor neurons of the olfactory epithelium; the output
is organized by the mitral cell axons. Additionally, infor-
mation can also be received from other parts of the
brain (amygdala, neocortex, hippocampus, locus coeru-
leus and substantia nigra). The peripheral olfactory system
has also been recognized as a model of postnatal neuro-
genesis, because it displays the most robust and functional
postnatal neurogenesis among neuronal populations that
maintain stem cells [3]. In addition, neurogenesis is in-
creased after lesioning of either the oB (termed bulbect-
omy) or the epithelium itself [4]. The epithelium contains
a mixed population of basal cells, basal daughter cells, im-
mature and mature olfactory receptor neurons (ORNs),his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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cells generate the new neurons that repopulate the olfac-
tory epithelium (OE) throughout life [7-10]. The presence
of stem cells in the adult brain which can develop into ma-
ture neurons in vitro suggests that postnatal neurogenesis
could be used to repopulate certain neuronal lineages
[11,12]. Therefore, different factors for neuronal precursor
proliferation and maturation have been determined (in-
cluding neurotrophins, neuropeptides, and cytokines
[13,14]). Despite the usage of certain mitogens, the prolif-
eration of neuronal stem cells can be induced in vitro. The
identification of factors that regulate and modulate the
maturation of neurons within the postnatal brain is critical
to the application of stem cell therapy [15-17].
According to Bandeira et al. [1], a postnatal increase
of the rat brain-mass occurs in the first 3 months after
birth (by a factor of ~20.7 in all brain areas). The time
course of changes in the postnatal brain can be divided
into 4 phases, the first 2 phases (first phase [P0-P2]: “idle
time“, no significant mass increase of the brain; second
phase [P2-P25]: heavy increase of the brain’s mass) can
be referred to all brain structures. Furthermore, from
P25 on, the hippocampus, oB and the rest of the brain
show a slow growth up to P90. The weight of body and
brain increases till P275, but much slower with rising
age [18].
For the postnatal changes in the number of neurons,
the rat brain generates between 1 and over 5 million
neurons per day during a period of 3–4 days. During the
first postnatal week, then, the number of neurons in-
creases by nearly 50% in the brain. At this stage, the
number of neurons is followed by a marked net loss of
neurons during the second postnatal week, when 60%–
70% of the number of neurons in the brain is lost. In
contrast, an addition of neurons proceeds in the oB until
adulthood. An identifiable period of neuronal loss within
adulthood is not detectable in this brain area. The gener-
ation and integration of new neurons is possible because
the rostral migratory stream (RMS) of the subventricular
zone (SVZ) at the anterior horn of the lateral ventricles
progressively fills up and replaces neurons of the oB which
degenerate [19-23]. It presents an active neurogenerative
region in adulthood (schematic overview, see Figure 1c).
Here, the progenitor cells proliferate continuously and dif-
ferentiate to granular and periglomerular cells in the oB
[23-27]. These progenitor cells migrate from the SVZ to
their functional destination in the oB. Studies by Luskin
[27], Lois and Alvarez-Buylla [23] and Luskin and Boone
[28] identified the migratory route as a pathway where the
velocity of migration constitutes 5 mm/7 days in the adult
rat and mouse between the anterior horn of the lateral
vesicle and the olfactory ventricle. The cells spread radially
towards the granular and periglomerular layers, where
they are thought to differentiate into neurons [23,27,29].In adult rats, this subependymal layer is a remnant of the
embryonic subventricular zone which originates after the
occlusion of the primitive olfactory ventricle where cell
proliferation can occur in the adulthood. This proliferation
is organized in a well-defined pathway of tangential and
radial migration. The migration is performed by a mesh-
work of astrocytic processes and cell bodies which form
long tangentially oriented canals. These canals act as phys-
ical barriers, allowing the deplacement of long chains of
migrating cells from the lateral ventricle to the oB and
prevent any dispersion along their tangential migration
route. Interestingly, cells inside these glial tubes contain
proteins like class 3 beta-tubulin [30]. This beta-tubulin
shows a diffuse staining which signals a not yet organized
form of mature finally assembled microtubules [26]. With
this mechanism, it is possible for neurons as well as for
progenitor cells (differentiated in the stem cell niche) to
migrate within the oB. The progenitor cells can differenti-
ate to dopamineric interneurons. The main period of ori-
gin of interneurons is located between P1 and P10, after
this period their development decreases. This means the
chosen period of P7 in this study can be seen as one of the
main peaks of generating interneurons.
Another major amount of olfactory interneurons are
the granular cells. This GABAergic cell type is important
for generating inhibition to regulate the processing of
sensory output. These cells are essential for learning and
for the manipulation of sensory experiences early in the
postnatal period. They are able to modify the structure
and function of the oB [31-34]. Regarding their morph-
ology, these cells are axonless interneurons and their
dendrites span several bulbar layers and have distinct
layer-specific features [35]. Furthermore, granular cells
run through considerable changes of their formation of
spines and filopodias. During development, three major
changes are known: decrease of stubby spines, accom-
panied by an increase in the frequency of typical spines,
then a distinct pattern of change in spine, filopodium
density in the different dendritic domains and an over-
shoot in the number of spinesor filopodia, respectively,
in the basal dendrites (peak at P28).
A main aspect during growth and development of the
rat brain are the expression- and activity changes of glyco-
lytic enzymes. For example, the activity of phospho-
fructokinase (a key enzyme which catalyzes the conversion
of fructose-6-phosphate to fructose-1, 6-bisphosphate and
which also represents the rate-limiting step in the glycoly-
sis) is detectable in fetal brains at the twelfth day of gesta-
tion. It shows little change in enzyme activity in the brain
from 5 days before birth to 8 day after birth. During this
period, activity was 30-40% of the normal value found in
an adult brain. After 12 days, a rapid increase in activity to
21 days occurred [36]. Furthermore, the activities of add-
itional glycolytic enzymes (hexokinase [37], aldolase [38],
Figure 1 Overview of the rat brain at the level of the olfactory bulb. (a) Horizontal section of a rat brain, (b) Magnified view of the olfactory
bulb. (c) Schematic overview of the migration of olfactory precursor cells (RMS).
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during maturation of the rat brain.
A main feature of Parkinson’s disease is the loss of
dopaminergic neurons in the substantia nigra [40].
Current therapeutic options of this neurodegenerative
disease are symptomatic and temporary only. The ex-
perimental investigation of optimizing therapeutic strat-
egies like stem cell transplantation in well described
experimental models of Parkinson’s disease, both in vitro
and in vivo are still essential [41]. From previous studies
[42,43], we know that transplanted progenitor cells in
the neonatal and adult striata develop differently in
neural and glial cell types. A better characterization of
the development of the microenvironment at the prote-
ome level may support a better understanding of sur-
vival and differentiation of transplanted progenitor cells.
In this study, proteins from the oB of juvenile, adult
and aged rats were separated by 2DE and identified by
MALDI-TOF-MS. Proteins which change their expres-
sion during ontogenesis were identified. As yet, protein
expressions in the developing proteome are not fullyunderstood. As mentioned before, stem cells of the oB
in the adult brain can develop into mature neurons
in vitro which suggests that postnatal neurogenesis could
be used to repopulate certain neuronal lineages [11,12].
Additionally, with the usage of certain mitogens and cyto-
kines, the proliferation of neuronal stem cells can be in-
duced [15-17]. Based on this, the oB seems an interesting
system to analyze differences in the expression of proteins
depending of its development.
Results
To identify the differences in the protein expression be-
tween the groups of different ages (P7, P90 and P637),
2DE with subsequent gel-matching, spot-warping and
differential spot analysis combined with protein identifi-
cation by MALDI-TOF-MS was performed. A precise,
manual labeling of the spots was realized by using the
software Progenesis PG200.
First, in Figure 1a, a horizontal section of the oB of a rat
brain is shown. In Figure 1b, a magnified view of the ana-
lyzed brain area (oB) is given. In Figure 1c, a schematic
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presented. Here, the olfactory precursor cells (stem cells,
transit amplifying cells) proliferate mainly in the SVZ
where the differentiation in immature neuroblasts also
happens. These neuroblasts then migrate through the
RMS to the oB. After a period of 5–7 days (after birth),
these neuroblasts shift towards the granular (granular cell
layer, GlC), periglomerular and external plexiform cell
layers of the oB. At a time of 15–30 days after birth, ma-
tured neuroblasts generate interneurons in the oB.
In Figure 2, the images of the reference gels of the differ-
ent developmental stages are presented ((a) P7, (b) P90
and (c) P637). The spot compositions turn out to be com-
parable. On average, 828 (±71) spots were detected in the
six gels of P7, 775 (±152) spots in the gels of P90 and 785
(±56) spots in the gels of P637. Furthermore, in Figure 3,
an example of the manual spot editing (segmentation,Figure 2 Overview of the reference gel images from the olfactory bu
The 2DE-gel image of a P7 animal is shown in (a). In (b) the 2DE-gel imag
oldest P637 rat.delineation) by using a gel image of the olfactory bulb in
Progenesis PG200 is shown.
The differentially expressed proteins were classified
into 13 functional protein groups. In the following, only
those proteins which show the most differential expres-
sion are described in detail (Figures 4(a) and 5(a)). A
complete overview of the expression changes of all ana-
lyzed proteins as well as a description of the remaining
protein categories is listed in Additional file 1.
In the following, a more detailed analysis of the up-
and down-regulation of the proteins from the different
categories and developmental stages in comparison to
P90 is described (4(b), 5(b)).
For P7, the carbohydrate metabolism consists of
14 proteins which are down-regulated in this stage
towards P90. For example, the protein 2-oxoglutarate
dehydrogenase (Ogdh) which catalyzes the overalllb. The coomassie blue stainings of the gels have similiar intensities.
e of a P90 animal is presented. (c) shows the 2DE-gel image of an
Figure 3 In order to perform an accurate segmentation of spots, the manual editing of spots was augmented by a 3D-visualization.
This procedure has been applied to all reference gels as well as to all template gels. An example of the latter is presented here.
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CO2 during the Krebs-cycle and which also participates
in mitochondrial degradation of glutamate shows a
down-regulation. Aconitate hydratase (Aco2) that cata-
lyzes the interconversion of citrate to isocitrate via
cis-aconitate in the second step of the TCA-cycle is
down-regulated as well. Another down-regulated protein
towards P90 is the gamma-enolase (Eno2) which has
neurotrophic and neuroprotective properties on a broad
spectrum of neurons. This expression pattern could also
be validated by Western Blot analysis of the same pro-
tein homogenates (Figure 6). It binds in a calcium-
dependent manner to cultured neocortical neurons and
promotes the survival of the cells. Furthermore, proteins
like glucose-6-phosphate 1-dehydrogenase (G6pdx), which
produces pentose sugars for nucleic acid synthesis and
which is a secondary antioxidant enzyme that plays an im-
portant role in detoxifying ROS/RNS by maintaining a sup-
ply of intermediates such as glutathione and NADPH are
differentially expressed. Glyceraldehyde-3-phosphate de-
hydrogenase (Gapdh), a protein involved in the important
energy-yielding step in carbohydrate metabolism, catalyzes
the reversible oxidative phosphorylation of glyceraldehyde-
3-phosphate and is also participating in the organization
and assembly of the cytoskeleton. Altogether 5 proteins in-
cluding alpha glucosidase (Ganab) with a hydrolytic func-
tion as well as transaldolase (Taldo1) are up-regulated at
this stage. Taldo1 presents an important regulator of me-
tabolites in the pentose-phosphate pathway, for example.
Furthermore, 4 proteins are absent at this stage. For ex-
ample, the protein 3-hydroxyisobutyrate dehydrogenase(Hibadh) plays a critical role in the catabolism of L-valine
by catalyzing the oxidation of 3-hydroxyisobutyrate to
methylmalonate semialdehyde. Fructose-bisphosphate al-
dolase C (Aldoc) which gets expressed specifically in the
hippocampus and in Purkinje cells of the brain, cata-
lyzes the reversible aldol cleavage of fructose-1.6-bipho-
sphate and fructose 1-phosphate to dihydroxyacetone
phosphate and either glyceraldehyde-3-phosphate or
glyceraldehydes. Glycerol-3-phosphate dehydrogenase 1-
like protein (Gpd1l) catalyzes the conversion of glycerol 3-
phosphate to glycerone phosphate. The protein isocitrate
dehydrogenase subunit alpha (Idh3a) catalyzes the oxida-
tive decarboxylation of isocitrate to 2-oxoglutarate.
As for the proteins of the biosynthesis, 13 proteins are
up-regulated. For example, the protein serine tRNA lig-
ase (Sars) catalyzes the attachment of serine to tRNA.
Additionally, different subunits needed for splicing (spli-
cing factor 3a, subunit 3 (Sf3a3)), elongation (elongation
factor 1-gamma (Eef1g)) and translation (eukaryotic
translation initiation factor 4A1 (Eif4a1)) display an up-
regulation. Furthermore, different members of the fam-
ily of the heterogeneous nuclear ribonucleoproteins
(hnRNPs) are up-regulated towards P90 (heterogeneous
nuclear ribonucleoprotein (Hnrnpf ), heterogeneous nu-
clear ribonucleoprotein C (Hnrnpc), heterogeneous nu-
clear ribonucleoprotein K (Hnrnpk)). These members
are essential for mRNA metabolism, DNA-related func-
tions and microRNA biogenesis. Four proteins are
down-regulated towards P90. These proteins are in-
volved in the metabolism of biosynthesis like the elong-
ation factor Tu (Tufm) or serine/threonine-protein
Figure 4 Differential expression of proteins in the olfactory bulb at P7. (a) Relative frequencies of proteins in the olfactory bulb that are
differentially expressed (P7 vs P90). (b) Number of differentially expressed proteins of different protein categories within the olfactory bulb [P7] vs
[P90]. (Abbreviations for Figure 4 (b) and Figure 5 (b): pcm: proteins carbohydrate metabolism, paam: proteins amino acid metabolism, pfm: proteins
fat metabolism, pem: proteins energy metabolism, pd: proteins degradation, pa: proteins antioxidants, ptm: proteins transmitter metabolism, pb:
proteins biosynthesis, pst: proteins signal transduction, pr: proteins regulation, cp: chaperones, sp: structural proteins, tp: transport proteins). Number of
up-regulated proteins for each category are shown in blue; down-regulated proteins (red); absent proteins in P7 (green) and in P90 (purple).
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(Ppp2r2a). One protein is absent in the gels from the P7
protein extract (ribose-phosphate pyrophosphokinase 1
(Prps1)) which catalyzes the phosphoribosylation of ribose
5-phosphate to 5-phosphoribosyl-1-pyrophosphate, neces-
sary for purine metabolism and nucleotide biosynthesis.
Three proteins are absent in the gels from the P90 protein
extract: The serine/arginine-rich splicing factor 3 (Sfrs3),
the RNA- binding motif protein, X-linked-like-1 (Rbmxl1)
and the putative RNA-binding protein 3 (Rbm3), a protein
which is expressed widely during early brain development
in glutamatergic and GABAergic cells as well as in newly
formed and migrating neurons, peaking in the first to sec-
ond postnatal weeks.The amount of up- and down-regulation of the struc-
tural proteins is more or less balanced. Thirteen proteins
are up-regulated at this stage. These proteins are mainly
involved in the dynamic organization of the cytoskeleton,
like actin-related protein 2 (Actr2), member of the Arp2/3
complex, dihydropyrimidinase-related protein 2 (Dpysl2)
or F-actin-capping protein subunit alpha-1 (Capza1). Other
up-regulated proteins are actin beta (Actb) which can sup-
port the acceleration of axonal outgrowth, for example, or
stathmin (Stmn1) involved in the regulation of the micro-
tubule filament system by destabilizing microtubules. Six
proteins are down-regulated towards P90. These are mainly
members of the neurofilament family (neurofilament light
polypeptide (Nefl), neurofilament medium polypeptide
Figure 5 Differential expression of proteins in the olfactory bulb at P637. (a) Relative frequencies of proteins in the olfactory bulb that are
differentially expressed (P637 vs P90). (b) Number of differentially expressed proteins of different protein categories within the olfactory bulb
[P637] vs [P90]. Same abbreviations and labeling performed as in Figure 4 (b); absent proteins in P637 (green) and in P90 (purple).
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ally maintain the neuronal caliber. They may also partici-
pate in intracellular transport to axons and dendrites.
This pattern of expression could also be validated by
Western blot analysis for the neurofilament medium
polypeptide as well as for the neurofilament light poly-
peptide (Figure 6). The tropomyosin alpha-3 chain is
the only protein which is absent at P90 in this category.
This protein has the ability to regulate the molecular
composition of microfilaments, which in turn regulates
the dynamic and functional properties of the resulting
actin filament population.
All in all, at developmental stage P7, a total of 129
proteins is expressed differentially towards P90, of which
63 proteins are up-regulated, 51 proteins are down-
regulated, 9 proteins are absent at P7 and 6 proteins are
absent at P90 (Table 1).For P637 in comparison to P90, differences in the ex-
pression are also remarkable. Beginning with the functional
group with the most differentially expressed proteins, the
structural proteins; this category consists of 7 proteins
which are up-regulated, 4 proteins which are down-
regulated. The up-regulated protein faction contains actin
beta (Actb) and myristoylated alanine-rich C-kinase sub-
strate (Marcks) which also shows an up-regulated expres-
sion at P7 towards P90. Other up-regulated proteins are
members of the tubulin family (tubulin alpha-1A chain
(Tuba1a), tubulin beta-3 chain (Tubb3), tubulin beta 4A
(Tubb4)). These proteins are generally required for the
organization of the cytoskeleton as well as migration and
differentiation of neurons, for example, by assembling mi-
crotubules into a highly organized mitotic spindle. The
down-regulated proteins contain lamin-B1 (Lmnb1) and
septin-11 (Sept11), for example. The protein Lmnb1
Figure 6 The validation of some differially expressed proteins
was performed by Western Blots (Mitogen-activated protein
kinase 1, 2 (Erk1,2), Phospho Mitogen-activated protein kinase
1, 2 (Erk1,2P), Neurofilament Low (NF-L), Neurofilament
Medium (NF-M) and Gamma Enolase (γ Enolase) in the olfactory
bulb between the different development stages (P7, P90, P637).
α-tubulin staining was used to ensure the equal loading of proteins.
This protein is expressed also differentially.
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gene expression) shows an up-regulation at P7 towards
P90 and Sept11 (filament-forming cytoskeletal GTPase, in-
volved in cytokinesis and vesicle trafficking) displays a
down-regulation at P7.
As for the regulatory proteins, 3 proteins are up-
regulated. These contain the Rab GDP dissociation in-
hibitor alpha (Gdi1) which is also up-regulated at P7 in
comparison to P90. Another protein is the Rap2-
interacting protein × (Rufy3) which is implicated in the
formation of a single axon of developing neurons. ATable 1 Overview of the differential expression of the









Absent P90 6 4total of 2 proteins (Rho GDP-dissociation inhibitor 1
(Arhgdia), annexin A5 (Anxa5)) is down-regulated.
Arhgdia is involved in the organization of the actin cyto-
skeleton in response to extracellular signals for proper
cell morphology, growth, proliferation, differentiation, mo-
tility and adhesion. The protein Anxa5, whose functional
meaning was described earlier, is also down-regulated at
P7 towards P90. One protein is absent at P637 (calcium
binding protein 39 (Cab39)). This protein presents a ne-
cessary element in cell metabolism that is required for
maintaining energy homeostasis. At P90 the protein my-
osin regulatory light chain 12B (Myl12b) is absent.
The proteins which are involved in pathways of the pro-
tein biosynthesis present 4 proteins which are up-regulated
and 1 protein which is absent at P637 (transcriptional
activator protein Pur-beta (Purb)). The up-regulated
group contains members of the heterogeneous nuclear
ribo-nucleoprotein family (heterogeneous nuclear ribo-
nucleoprotein F (Hnrnpf ), heterogeneous nuclear ribo-
nucleoprotein K (Hnrnpk)). These proteins are relevant
for mRNA metabolism, DNA-related functions and
microRNA biogenesis.
At P637, all in all 47 proteins are expressed differentially
towards P90, of which 25 proteins show an up-regulation,
14 proteins show a down-regulation, 4 proteins are absent
at P7 and 4 proteins are absent at P90 (Table 1).
Discussion
In the following, the identification and characterization
of differentially expressed proteins in the oB during the
postnatal day of development (P7 and P637) in compari-
son to P90 will be discussed.
In general, the oB does not consist of a homogeneous
cell population. Therefore, a differential proteome ana-
lysis is a representation of proteome changes of the
whole oB concerning all cell populations and the neuro-
pile. The separation technique used in this study allows
protein separation within the range of approximately
10–100 kDa and between a pH-range of 3–10. For this
reason, it is possible to analyze a substantial part, but
not the entire proteome of the oB [44]. Moreover, some
parts of the gel may show a lower resolution which can
lead to a misinterpretation of the regulation analysis of
some protein spots. Furthermore, it is known that pro-
teins may be represented by multiple spots with different
locations in the gel which can result from different post-
translational modifications and isoforms of the same
protein. Therefore, several proteins may show specific
regulation changes for one spot only and not for the entire
protein. By applying other mass spectrometric detection
methods like the stable isotope ratio mass spectrometry
(SIRMS), it would be possible to unambiguously identify
both the protein and its variants and to overcome the
sample-to-sample recovery variabilities associated with
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usage of affinity-enrichment-MS methods (e.g. IDB-
EST™, iTRAQ™) would enhance the possibility for tar-
geted biomarker discovery applications to drill down to
lower-abundance proteins and to improve its analysis
[45]. Hence, the results of the presented proteome ana-
lysis of the rat oB should be considered as a first step to
elucidate the patterns of proteins which are differen-
tially expressed in this region of the brain.
This study focuses on proteins that differed in abun-
dance and give indications for developmental changes in
the oB. Expression levels of proteins were determined and
their changes were interpreted by comparison with regard
to the literature. Specific changes of cytoplasmatic pro-
teins of the postnatal developing oB were found.
At P7 in comparison to P90, those proteins which are
involved in carbohydrate metabolism, biosynthesis, amino
acid metabolism and regulatory as well as structural
proteins show an increased expression. For the protein
expression at P637 versus P90, proteins of the energy
metabolism, proteins involved in biosynthesis, chaper-
ones, regulatory and structural proteins show various
changes in their expression.
The majority of differentially expressed proteins of the
carbohydrate metabolism are down-regulated at P7 with
comparison to P90. Most of these proteins are involved
in the tricarboxylic acid cycle and glycolysis. For ex-
ample, the protein 2-oxoglutarate dehydrogenase (Ogdh)
which catalyzes the conversion of alpha-ketoglutarate to
succinyl-CoA and CO2 during the Krebs-cycle and
which also participates in mitochondrial degradation of
glutamate [46] shows a down-regulation at P7. Other pro-
teins like aconitate hydratase (Aco2) participating in the
interconversion of citrate to isocitrate or the protein
gamma-enolase (Eno2) which catalyzes the conversion of
2-phosphoglycerate to phosphorenolpyruvate and which
also has neuroprotective properties [47] are involved in
these pathways. Already Wilbur et al. [48] found that the
activities of several proteins involved in tricarboxylic acid
cycle as well as of the pyruvate metabolism show low ex-
pression levels in newborn rats, whereas they are in-
creased markedly to adult levels during 10–30 postnatal
days but do not decrease in adulthood.
The majority of proteins which are involved in the pro-
cesses of protein biosynthesis display an up-regulation at
P7 in comparison to P90. Especially proteins for splicing
(splicing factor 3a, subunit 3 (Sf3a3)), elongation (elong-
ation factor 1-gamma (Eef1g)) and translation (eukaryotic
translation initiation factor 4A1 (Eif4a1)) are up-regulated.
Of particular relevance in the mammalian nervous system
are transcripts exhibiting multiple splicing patterns, par-
ticularly important growth processes such as axon guid-
ance, synaptogenesis, and the regulation of membrane
physiology [49-51]. Furthermore, different members of thefamily of the heterogeneous nuclear ribonucleoproteins
(hnRNPs) are up-regulated towards P90 (heterogeneous
nuclear ribonucleoprotein (Hnrnpf), heterogeneous nu-
clear ribonucleoprotein C (Hnrnpc), heterogeneous nu-
clear ribonucleoprotein K (Hnrnpk)). These members
generally play key roles in mRNA metabolism, DNA-
related functions and microRNA biogenesis. In general,
regulation of stability, localization and translation of a
number of transcripts are important in the establishment
and maintenance of nerve cell functions [52-56]. The
regulation of the expression of many RNAs depends on
the activity of RNA-binding proteins, often acting in con-
cert and organized in complexes, probably regulating the
activity and the expression of the other components of the
complex itself [57]. These complexes contain elements
involved in the control of different aspects of RNA metab-
olism, including the interactions established by heteroge-
neous nuclear proteins (hnRNPs) during the transport of
the mRNAs from nucleus to cytoplasm and to the site of
translation. They also contain mRNA–proteins and pre-
mRNP complexes which can be actually found in associ-
ation with the cytoskeleton. Models have been proposed
about the role of cytoskeleton-associated hnRNPs in
mRNA biogenesis-control at the post-transcriptional
level [58,59]. For example, hnRNPK and the Abelson-
interacting protein 1 (Abi-1) can act in a synergistic
manner in a multiprotein complex that regulates the
crucial balance between filopodia formation and synap-
tic maturation in neurons [60].
Especially proteins for the dynamic organization of the
cytoskeleton are up-regulated at the early developmental
stage of P7, as, for example, the actin-related protein 2
(Actr2) which is a member of the Arp2/3 complex. This
complex is a stable assembly of two actin-related proteins
(Arp2 and Arp3) and subsequently five other proteins.
This nucleator acts by serving as a template for monomer
addition by mimicking the barbed end of a growing fila-
ment [61]. This complex gives rise to branched actin fila-
ments, as the complex binds to the sides of actin mother
filaments and remains associated with the pointed end
leaving the barbed end free to elongate [62,63]. Other up-
regulated proteins (F-actin-capping protein subunit alpha-
1 (Capza1), actin beta (Actb), stathmin (Stmn1)) are also
involved in the dynamic organization which can support
neuronal differentiation, including axonal growth and
branching, or dendritic development [64]. In addition,
Kaltwasser et al. [65] and Stühler et al. [66] reported that
with increasing age a down-regulation of Stmn1 could be
observed in the rat brain. Some members of the neurofila-
ment family are down-regulated (neurofilament light poly-
peptide (Nefl), neurofilament medium polypeptide (Nefm)).
These are involved in the promotion of axonal growth,
neuronal polarity through direct binding to tubulin and
known to be required for signaling in axon guidance [67].
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arborization are crucial for the proper postnatal develop-
ment of the nervous system. It suggests that levels of activ-
ity at individual synapses can locally modify the structure of
the postsynaptic neuron. Furthermore, most of the extra-
and intracellular signals that influence dendritic growth also
alter synapse formation and axon guidance. This means
that especially in the first postnatal days, the development
of neurons and formation of synapses e.g. is essential, there-
fore, a dynamic expression of structural proteins is import-
ant at this stage of development.
A comparable development expression is also detectable
for regulatory proteins. This category includes 8 up-
regulated proteins and 4 down-regulated proteins. Cofilin-
1 (Cfl1) and neuromodulin (GAP-43) among others
belong to the up-regulated proteins at P7. Cfl1 has the
property to directly regulate actin dynamics, severing and
depolymerizing actin filaments to generate new barbed
ends for an initiation of the actin polymerization. One of
the best characterized ways of regulation is the phosphor-
ylation on serine 3 that inhibits its F-actin activity [69].
Moreover, Sparrow et al. [70] showed, that cofilin plays an
essential role during myelination in combination with
neuregulin-1. This presents a highly specialized form of
cell motility in which protrusive expansion of the leading
edge of the inner mesaxon, accompanied by high rates of
membrane synthesis, drives the glial membrane repeatedly
around the axon to generate the myelin sheath. As stated
by Philpot et al. [71], a proper formation of myelin has im-
portant consequences for the physiological function. They
were able to show that an increased myelination occurs in
the oB beginning about P11 and continues through P30.
These results are corroborated by the appearance and
rapid increase in expression of myelin-specific mRNAs in
the rat bulb from P10-P15 [72]. The protein neuromodu-
lin (GAP-43) presents a neuron-specific phosphoprotein
that appears to be participating in the development and
functional modulation of synaptic relationships [73]. Dur-
ing development, GAP-43 is one of a small number of
proteins that is expressed selectively in association with
process outgrowth [74]; its synthesis and axonal transport
persist at high levels throughout axogenesis and synapto-
genesis, and then decline precipitously with the establish-
ment of stable synaptic relationships [75-81]. Jacobson
et al. [82] observed that throughout the rat brain as a
whole, levels of GAP-43 are highest during the first post-
natal week, a period in which synaptic organization is still
taking place, then fall by more than 90% over the next few
weeks. For the down-regulated proteins, e.g., members of
the annexin family (annexin A3 (Anxa3), annexin A5
(Anxa5)) show a lower amount of expression compared to
P90. An accumulation of annexin 5 in cultured glioma
cells during differentiation rather than proliferation could
be shown by Giambanco et al. [83]. It is known that braindevelopment and maturation in the rat are postnatal
events, consisting of glial cell proliferation and differenti-
ation after the tenth postnatal day and in synaptogenesis
during the third and fourth postnatal week [84-86]. Fur-
thermore, Giambanco et al. [83] provided evidence that
the accumulation of annexin 5 shows a sharp increase
after the first postnatal week which appears to be in line
with the possibility that the expression of this protein
might be related to brain development.
The proteins of the amino acid metabolism show a
higher amount of down-regulated proteins (7 proteins)
than up-regulated proteins (2 proteins). The protein GMP
synthase (GMPS) is an example for an up-regulated pro-
tein in comparison to P90 in this category. GMP synthe-
tase is a key enzyme in the de novo synthesis of guanine
nucleotides [87]. In the guanine nucleotide pathway, two
enzymes are involved in converting IMP (inosinmonopho-
sphat) to GMP. Here, GMP synthetase catalyzes the ami-
nation of XMP (Xanthosinmonophosphat) to GMP. The
accumulation of guanine nucleotides is not only essential
for DNA and RNA synthesis, but it also provides GTP,
which is involved in a number of cellular processes im-
portant for cell division. GTP hydrolysis is also re-
quired for protein glycosylation [88], synthesis of
adenine nucleotides [89], protein translation [90], acti-
vation of G-proteins [91] and microtubule assembly
[92] which presents a possible explanation for the up-
regulated expression of the protein at P7 compared to
P90. A dynamic organization of the cytoskeleton is essen-
tial for neuronal differentiation (axonal growth and
branching, dendritic development) in the early stages of
development. Furthermore, a higher amount of down-
regulated proteins was detectable at this postnatal devel-
opmental stage for the regulatory proteins. As mentioned
earlier, the protein glutamine synthetase (Glul) displays a
lower expression at P7 than at P90. Also Patel et al. [93]
presented a differential pattern within development for
this protein in different brain regions. At birth, the protein
activity was the highest in the oB followed by forebrain
and cerebellum (these data are not shown here). The de-
velopmental increase in enzyme activity was more or less
linear in the forebrain and oB up to 20 days and in the
cerebellum up to 50 days. This suggests an increase in glu-
tamine synthetase activity which is associated with the mat-
uration process rather than the proliferation of astrocytes.
Another protein which is down-regulated is glutamate
dehydrogenase 1 (Glud1) which catalyzes the reversible
interconversion between glutamate and α-ketoglutarate.
Glutamate serves as an important metabolite in the central
nervous system [94] and is present in high concentrations
in the brain [95-97]. The development of glutamate de-
hydrogenase activity in the whole brain has been shown to
be low immediately post partum, however, its activity in-
creases towards the adult brain [98-100]. Furthermore, as
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ate dehydrogenase activity development correlates in-
versely with the decreasing ammonia concentrations
observed in the rat brain as the animal gets older, suggest-
ing a role for this enzyme in ammonia detoxication. Glu-
tamate dehydrogenase may also be potentially required in
the maintenance of glutamate and, by further metabolism
of γ-amino butyric acid, in neurotransmitter function,
whereas this property varies not only with the age of the
animal but also with the region of the brain.
Differential protein expression was also observed in
aged rat brains (P637). The main differences in the ex-
pression concerned the categories of proteins of the en-
ergy metabolism, proteins of the biosynthesis, regulatory
proteins, chaperones and structural proteins.
As described in the results, the expression of 3 proteins
involved in the energy metabolism displays an up-
regulation (e.g. creatine kinase B chain (Ckb) and cyto-
chrome c oxidase subunit 5B (Cox5b)). The protein ATP
synthase subunit alpha (Atp5a1) is down-regulated towards
P90. As stated by Villa et al. [102], there is clear evidence
that the oxidative energy metabolism gradually decreases
with aging and the capacity of the brain to meet stress con-
ditions is reduced with advancing age. Also Turpeenoja
et al. [103] described that mitochondria from old animals
contain less respiratory units than those from young ani-
mals and that the energy transduction capability is im-
paired by aging. They could observe two inner membrane
proteins (cytochrome b and subunit II of cytochrome oxi-
dase) which showed an age-related increase and they as-
sumed the abundance of these proteins may be related to
a decreased degradation rate leading to the accumulation
of some polypeptides, including abnormal and inactive
forms of proteins. This might cause partial inactivation of
some enzymes with a concomitant decline in their specific
activity. It has been postulated that senescent cells have re-
duced capacity to selectively identify and degrade defective
proteins [104] with the consequence of accumulating
functionally inactive polypeptides.
The proteins involved in protein biosynthesis reveal a
higher expression (members of the heterogeneous nu-
clear ribo-nucleoprotein family (heterogeneous nuclear
ribonucleoprotein F (Hnrnpf), heterogeneous nuclear ri-
bonucleoprotein K (Hnrnpk)) at P637 in comparison to
P90. As stated above, these proteins are involved in
mRNA metabolism, DNA-related functions and micro-
RNA biogenesis. This also includes processing in alter-
native splicing during neuronal differentiation [52]. As
stated by Tollervey et al. [105], especially genes with
metabolic functions show expression changes during aging
which is linked with alternative splicing. This indicates
that alternative splicing complements the transcriptional
regulation in modifying the molecular machinery for the
repair of oxidative DNA damage in the brain [106,107].Also regulatory proteins exhibit major changes in the
expression at P637 versus P90; the protein Rab GDP dis-
sociation inhibitor alpha (Gdi1), for example, is up-
regulated at this stage as well as at P7 compared to P90.
This protein is a regulator of transport processes such as
vesicular trafficking, docking off transport vesicles with
their corresponding acceptor membranes [108] which is
important at early stages of development. The higher ex-
pression of this protein at later stages, in this case at
P637, could be inferred as an effect leading to endoplas-
mic reticulum-associated protein degradation by either
the proteasome or macroautophagy pathway at higher
age [109]. However, this expression pattern could not be
shown for Rho GDP-dissociation inhibitor 1 (Arhgdia)
and annexin A5 (Anxa5)) which show a down-regulation
at P637. The calcium-binding protein 39 (Cab39) could
not be detected at this developmental stage. As Iacopino
et al. [110] described with the analysis of decreased ex-
pression of 28 kDa calbindin-D, another calcium-binding
protein, in 27-month-old rat brain tissue, aging in both
the rat and human central nervous system is accompanied
by increased intracellular levels of free calcium, reduced
activity of Ca2+/Mg2+-ATPase, and a decreased ability of
the mitochondria to sequester calcium [111,112]. This al-
tered calcium homeostasis is affected by both normal
aging and various neurodegenerative diseases.
Moreover, the group of chaperones contains proteins
which have a differential expression at the analyzed de-
velopmental stages. For example, two members of the
heat shock protein 90 family (HSP 90-alpha (Hsp90aa1),
heat shock protein HSP 90-beta (Hsp90ab1)) show an
up-regulation towards P90. As described by Proctor
et al. [113], neurodegeneration is an age-related disorder
which is characterized by the accumulation of aggre-
gated protein, loss of protein homeostasis and neuronal
cell death. Two central systems in protein homeostasis
are the chaperone system (includes Hsp90), which pro-
motes correct protein folding, and the cellular proteo-
lytic system, which degrades misfolded or damaged
proteins. A stochastic model of Hsp90 [114] showed that
under conditions of low or transient stress, chaperone
capacity is sufficient to maintain protein homeostasis.
Even under conditions of increasing stress with age, nor-
mal chaperone capacity is able to process the increasing
overload due to the mechanism of up-regulation of HSPs
after stress. This observation could also be the reason for
the up-regulation of the proteins in our analysis. However,
other proteins (T-complex protein 1 subunit beta (Cct2))
which are also involved in chaperone activity show a
down-regulation towards P90 or are absent at this stage
(protein disulfide-isomerase A3 (Pdia3)). Also Vanguilder
and Freeman [115] mentioned a decreased expression of
these proteins as an example for age-related dysregulation,
which indicates a loss of protein quality regulation that
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increased neurofilament light chain and tubulin) with in-
creasing age.
The category of structural proteins showed 7 up-
regulated proteins (actin beta (Actb), myristoylated
alanine-rich C-kinase substrate (Marcks) as well as sev-
eral members of the tubulin family (tubulin alpha-1A
chain (Tuba1a), tubulin beta-3 chain (Tubb3), tubulin
beta 4A (Tubb4)). It could be hypothesized that the up-
regulation of these structural proteins might be due to
the cytoskeletal dynamics in age-related neuronal dys-
function which was mentioned above. An indicator for
this circumstance could also be the down-regulation of
other structural proteins (lamin-B1 (Lmnb1) and septin-
11 (Sept11)) towards P90. This means, by up-regulating
the expression of established structural proteins, the or-
ganism tries to counteract the loss of essential neuronal
key elements during aging by maintaining the functional
organization of the cytoskeleton in general, for example.
Five differentially expressed proteins were validated in
Western Blots (Figure 6). In comparison to the 2DE-
analysis (Figure 7), the same developmental expression
changes of these proteins were detectable. All of these pro-
teins are involved in generating and regulating cell pro-
cesses, axons, dendrites and also processes of glial cells.
Beyond that it could be established that additional differ-
entially expressed proteins of the three developmental
stages are involved in proliferation, migration and differ-
entiation. Protein-members of the energy and amino acid
metabolism, for example, as well as the structural proteins
show that the maintenance of the oB with substrates dif-
fers during the development of the rat brain. Some of these
proteins could be candidates for further investigation re-
garding the survival and differentiation of transplanted
progenitor cells in neonatal and adult striata. This also
gives the option to connect the differentially expressed pro-
teins to their specific metabolic pathways in future studiesFigure 7 Left side: overview of a control gel (P90) with rectangles (a-
Right side: Magnification of the marked regions (a-d) for each developmenand to analyze factors and candidates which influence the
differentiation of neuronal progenitor cells.
Furthermore, a differential expression of proteins was
also detectable in brains of adult and aged rats (P90,
P637). This could be an indicator for the capability of
the oB to still generate and integrate cells of the nervous
system by the RMS of the SVZ in adulthood. In general,
the oB is of special interest as it reveals spontaneous
neurogenesis throughout the entire lifetime, suggesting
that it plays a functional role in physiological cell re-
placement in aging, learning and cognition, as well as
proposing a therapeutic potential in neurological dis-
eases [13,116], including neurodegenerative disorders
like Alzheimer’s and Parkinson’s disease.
Conclusions
In conclusion, the proteomic analysis of the oB at three
different developmental stages (P7, P90, P637) indicates
several changes of protein expression including up- and
down-regulation of single proteins or the appearance of
proteins at specific developmental stages only, support-
ing the concept of an extraordinarily high plasticity of
this part of the rat brain.
Yet, the performed differential 2D gel spot abundance
analysis does not exclude the simultaneous presence of pro-
teins/isoforms with no detectable abundance differences.
However, the analysis may contain the same proteins
other than that identified as differential with regards to its
abundance. As listed in the results, some abundant pro-
teins also show an absence at single developmental stages
which may result from different posttranslational modifica-
tions. However, the aim of the present study was not to
characterize structural differences of the same protein in
different spots but rather to detect protein spots that dif-
fered in abundance and provide indications for the changes
in protein expression during development. For the precise
analysis of expression changes of single proteins, furtherd) around regions of spots with differentially regulated proteins.
tal stage (P7, P90, P637). Each spot is marked by a circle.
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protein were detected to determine its exact differential
regulation. This also includes spots which are located in re-
gions of the gel that show a lower resolution, for example.
In this study, a relative small amount of proteins is
considered to be expressed differentially by applying a
restricted SVQ of greater 1.67 and smaller 0.6. An add-
itional analysis of extensive SVQ ranges (e.g. P0, P20,
P40, P200) could give a more detailed view about the de-
velopment of the oB. Furthermore, usage of additional
methods (e.g. difference gel electrophoresis, DIGE) could
increase the systems sensitivity, and reproducibility. Also
an additional usage of purification protocols could pro-
vide a more detailed view on small proteins (e.g. neuro-




Male Wistar rats (Rattus norvegicus, Charles River,
Sulzfeld, Germany) of different ages (7, 90, 637 postna-
tal days) with 6 animals in each group were used
[117,118]. The animals were housed at 22 ± 2°C under
an artificial day and night rhythm with a 12 h light–dark
cycle with free access to water and standard nutrition.
All animal treatment and experimental procedures were
conducted in compliance with the regulations and licens-
ing of the local authorities (Landesamt für Landwirtschaft,
Lebensmittelsicherheit and Fischerei Mecklenburg
Vorpommern, Germany) and the Animal Care and Use
Committee of the University of Rostock. According to
the European Communities Council Directive of 24th
November 1986 (86/609/EEC) and in accordance with
the above-mentioned local authorities adequate mea-
sures were taken to minimize pain or discomfort.
Perfusion and dissection
Perfusion was performed at defined dates (7, 90, 637 days
postnatal). The animals were anesthetized with ether
and killed by intraperitoneal Pentobarbital-Na+-injection
(60 mg/kg BW). Transcardial perfusion was performed
with 100 – 400 ml (bodyweight depending) cooled (4°C)
0.9% NaCl- solution. After decapitation and brain dissec-
tion, the dissected brain regions were weighed and
stored at −80°C until homogenization. From pentobar-
bital injection to −80°C storage it took less than 5 min.
Homogenization
Protein extraction was performed according to published
standardized protocols [119,120]. The brain sections
were incubated with (9 × probe mass [mg]) μL lysis buf-
fer consisting of 7 M urea (Sigma, Steinheim, Germany),
2 M thiourea (Sigma), 4% CHAPS (Sigma), 70 mM DTT
(Sigma), 0.5% Bio-Lyte Ampholytes pH 3–10 (Fluka,Buchs, Switzerland) and a mixture of protease inhibitors
(Roche, Basel Switzerland) additionally enriched with
(0.1× probe mass [mg]) μL Pepstatin A and PMSF
(Fluka) and snap-frozen at −150°C. The samples were
quickly thawed and transferred into a 2 mL Wheaton pot-
ter (neo-lab, Heidelberg, Germany) for homogenization.
Glass beads (Roth, Karlsruhe, Germany) were added to
the suspension, following a 15 s sonication, 15 s vortexing,
which was repeated six times and finished by shock freez-
ing the suspension at 150°C. The samples were quickly
thawed. They were put in a beaker on a magnetic stirrer
that was filled with ice water for 15 min. Finally, the sam-
ples were centrifuged at 17.860 × g for 20 min at 4°C. The
supernatant was very carefully removed using a 2 ml syr-
inge (Becton Dickinson, Heidelberg, Germany) with a
0.5 × 25 mm needle (Becton Dickinson), because of a thick
lipid coverage derived from myelinated nerve fibers. The
protein concentration of the supernatant was determined
by the Bradford assay.
Two dimensional polyacrylamide gel electrophoresis (2DE)
Rehydration
The first dimension was performed in a PROTEAN IEF
cell system (Bio-Rad, CA, USA). Protein extracts of 1 mg
protein were loaded on immobilized pH 3–10 nonlinear
gradient strips with a length of 17 cm (GE-Healthcare,
Art.: 17-1235-01) and actively rehydrated with 300 μL re-
hydration buffer consisting of 6 M urea (Sigma), 2 M thio-
urea (Sigma), 2% CHAPS (Sigma), 16 mM DTT (Sigma),
0.5% Bio-Lyte Ampholytes pH 3 10 (Fluka) at 50 V for
12 h at 20°C.
First dimension: isoelectric focussing
After rehydration, electrode wicks (Bio-Rad) were added
to reduce artifacts. Focusing started with the “condition-
ing step” (2 h) which subdivides in 2 sub-steps: (a) linear
voltage rise to 500 V, step-hold 30 min, (b) linear voltage
rise to 2500 V, step-hold 1 h. After that, the “slow volt-
age ramping” (2.5 h): quadratic voltage rise to 8000 V
and the “final focusing”: actual process of focusing (dur-
ation: 50.000 Vhrs) were performed. During the whole
IEF the temperature was constantly kept at 20°C. After
focusing the strips were stored at −80°C.
Second dimension: polyacrylamide gel electrophoresis
Focused IPG-strips were equilibrated in two steps of
30 min each in 5 mL of freshly prepared SDS equilibration
solution consisting of 1.5 M Tris–HCl pH 8.8 (Roth), 6 M
urea (Sigma), 30% Glycerol (Sigma), 2% SDS (Sigma), trace
of bromophenol blue (Roth) supplemented with 10 mg/mL
DTTand 40 mg/mL iodoacetamide.
The strips were transferred on 12% homogeneous self-
cast sodium dodecyl sulfate polyacrylamide gels
(200 mm × 250 mm × 1.5 mm). They were run at 125 V
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Plus Dodeca Cell (Bio-Rad). A cooling device (Julabo
F10, Julabo Labortechnik, Seelbach, Germany) was used
to ensure a constant buffer-temperature of 10°C.
Fixation and staining
Fixation was performed with acetic acid-methanol-
solution (45% methanol, 1% acetic acid overnight. Stain-
ing of the gels was performed in a colloidal CBB G250
solution (1 g/1000 ml) (Roth) as described previously
[121]. After 24 h, the gels were destained with ultra pure




The stained gels (n = 6) were scanned as 12 bit gray scale
tif-images with a F4100 scanner (Heidelberg, Heidelberg,
Germany) at 300 dpi resolution. Gels were rinsed in 0.02%
sodium azide (Aldrich Chemie, Steinheim, Germany),
shrink-wrapped in plastic and stored at 4°C until picking
for MALDI-TOF-MS.
Digital gel processing
For 2DE-gel image analysis, the software package Pro-
genesis PG200 Version 2006 (Nonlinear Dynamics Ltd.,
Newcastle upon Tyne, U.K.) was used. Each develop-
mental stage (P7, P90, P637) consisted of six gel images.
For P90 and P637, each gel image presents a single dis-
sected brain region, whereas in P7 the samples were
pooled for 2DE. The gels were registered to a reference
gel (the gel which contained most spots with highest
separation and staining quality and least artifacts) and
manually edited spots were matched to allow compar-
ability of all gels.
Determination of differentially abundant protein spots
Protein spots in 2DE were quantified by normalizing spot
volumes using the Progenesis PG200 and spot volume dif-
ferences were calculated. After the comparison of the nor-
malized gray value-spot volumes of all generated spot
pairs with Access and Excel (Windows, Microsoft), the
comparison of the spot volumes was determined by calcu-
lation of the spot volume quotient (SVQ, P90/P7 or P90/
P637). Only those spots were considered to be signifi-
cantly up- or down-regulated that showed a SVQ (Spot
Volume Quotient) of 0.6 or less and 1.67 or greater. The
differences were evaluated significantly if differentially
expressed spots in at least four gel images (correlated
spots) were detected which belong to one test group. If
multiple spots of one protein were detected by mass spec-
trometric analysis, the differential expression was deter-
mined by the mean of their individual expression levels. If
the differential expression tendency was ambiguous, theprotein expression is marked as “up-down” (see Additional
file 1: Table S1). The classification of the differentially
expressed proteins in their respective functional protein
groups itself was generated by a comparison of the proteins
properties; in addition, the basic function of each protein is
briefly described (according to Entrez Gene, GeneCards,
UniProtKB/Swiss-Prot, and/or UniProtKB/ TrEMBL).
Mass spectrometric analysis of protein spots
Protein spots were excised from the gels with a spot
picker (Flexys Proteomics picker, Genomic Solutions,
Ann Arbor, MI, USA), transferred into 96-well plates,
and subjected to in-gel digestion with trypsin. The gel
plugs were washed twice with 30% acetonitrile (ACN) in
25 mM ammonium bicarbonate and 50% ACN in
10 mM ammonium bicarbonate, respectively, shrunk
with ACN, and dried at 37°C. The dried gel plugs were
re-swollen with 5 μl protease solution (sequencing grade
trypsin, 10 ng/μl in 3 mM Tris–HCl, pH 8.5, Promega,
Madison, WI, USA) and incubated for 8 h at 37°C.
Thereafter, 5 μl of extraction solution (0.3% trifluoroace-
tic acid, 50% ACN) were added and the samples were
agitated at room temperature for 30–60 min before the
peptide extracts were transferred into the 96-well collec-
tion plates. The resulting peptide-containing solution
was prepared for MALDI analysis by spotting 0.6 μl of
the tryptic digest and 0.45 μl of matrix solution consist-
ing of 9 mg/ml α-cyano-4-hydroxy-cinnamic acid
(CHCA) in 50% ACN, 0.1% trifluoroacetic acid on stand-
ard stainless steel MALDI plates. MALDI-MS analysis was
performed on a 4700 Proteomics Analyzer MALDI-TOF/
TOF mass spectrometer (Applied Biosystems, Foster City,
CA, USA). All acquired spectra were processed using
4700 Explore™ software (Applied Biosystems). For protein
identification, spectra were submitted to MASCOT (ver-
sion 2.4.0, Matrix Science, London, UK) via the MASCOT
Deamon. Searches were performed against the subset of
rat proteins of the UniProtKB protein sequence database
(2012_01; 42755 sequences from Rattus). A mass toler-
ance of 60 ppm and 1 missing cleavage site were set, oxi-
dation of methionine residues was considered as variable
modification, and carbamidomethylation of cysteines as
fixed modification. Peptide masses of trypsin autoproteoly-
sis products and matrix-derived peaks were excluded.
Identifications with Mascot scores greater than 59 were
considered significant (p < 0.05). All results were examined
carefully for reliability and occurrence of multiple proteins
in the same sample.
Immunoblot analysis
The homogenated protein samples of the oB were
dissolved in sample buffer containing 1% SDS and
boiled for 10 min. Protein contents in the samples were
determined according to Neuhoff et al. [122]. For
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were separated by SDS-Page using 7,5% polyacryamide
gels and transferred to PVDF membranes (0.2 mm, Bio-
Rad, Munich, Germany). The blots were blocked with 5%
non-fat dry milk powder in TBS for 30 min and incu-
bated with the individual primary antibodies. The fol-
lowing antibodies were used (dilutions are given in the
brackets): rabbit polyclonal anti-Gamma-enolase (1:500),
mouse monoclonal anti –α Tubulin (1:1000), goat mono-
clonal anti-neurofilament medium (1:2000), mouse mono-
clonal anti-neurofilament low (1:500), rabbit polyclonal
anti-Erk 1,2 (1:500) and mouse monoclonal anti-Erk 1,2 P
(1:500). After washing, membranes were incubated with
secondary HRP-conjugated anti-mouse (1:2000), anti-goat
(1:2000) and anti-rabbit (1:2000) IgG, and visualized by
the enhanced chemiluminescence (ECL) procedure as
described by the manufacturer (Thermo scientific,
Pierce, Rockford, USA).
Additional file
Additional file 1: Some differentially expressed proteins of the
categories of P7 P90 and P637 which are not listed in the results
are presented and described. In Table S1. Remaining categories of
differentially expressed proteins of P7 in comparison to P90. Table S2.
Remaining categories of differentially expressed proteins of P637 in
comparison to P90.
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